Literature DB >> 28848929

The 2017 Update to the COPD Foundation COPD Pocket Consultant Guide.

Barbara Bp Yawn1, Byron Thomashaw2, David M Mannino3, MeiLan K Han4, Ravi Kalhan5, Stephen Rennard6, Scott Cerrata7, James D Crapo8, Robert Wise9.   

Abstract

The COPD Foundation Pocket Consultant Guide (PCG) was first released in 2007 as a practice tool for use at point of service for clinicians, especially primary care clinicians diagnosing and treating patients with chronic obstructive pulmonary disease (COPD). Over the years, the PCG has been supplemented with a mobile app that presents the tool in an online smart phone accessible version that also allows the clinician to enter patient specific data for guidance to next steps of diagnosis or management. In November 2016, a new update of the PCG was released that incorporates a flow diagram for stepped care that includes the newest recommendation for diagnosis, assessment and treatment; including the broad use of dual bronchodilator therapy and consideration of asthma COPD overlap syndrome (ACOS). The current controversy regarding when to add inhaled corticosteroids (ICSs) is addressed to support clinical decision making. The PCG comes in 2 versions, one with generic names for COPD drugs available in the United States and one with trade names for those drugs. The update continues to recommend spirometry for those at highest risk, also emphasizing the need to assess symptoms, exacerbation risks and comorbidity before selecting appropriate non-pharmacological as well as pharmacological therapy. The tool is designed to facilitate COPD management in daily practice.

Entities:  

Keywords:  GOLD; care recommendations; chronic obstructive pulmonary disease; copd; guidelines; point of care; primary care

Year:  2017        PMID: 28848929      PMCID: PMC5556909          DOI: 10.15326/jcopdf.4.3.2017.0136

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN: 2372-952X


  15 in total

1.  Introducing the COPD Foundation Guide for Diagnosis and Management of COPD, recommendations of the COPD Foundation.

Authors:  Stephen Rennard; Byron Thomashow; James Crapo; Barbara Yawn; Andrew McIvor; Scott Cerreta; John Walsh; David Mannino
Journal:  COPD       Date:  2013-06       Impact factor: 2.409

2.  Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.

Authors:  Amir Qaseem; Timothy J Wilt; Steven E Weinberger; Nicola A Hanania; Gerard Criner; Thys van der Molen; Darcy D Marciniuk; Tom Denberg; Holger Schünemann; Wisia Wedzicha; Roderick MacDonald; Paul Shekelle
Journal:  Ann Intern Med       Date:  2011-08-02       Impact factor: 25.391

3.  Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.

Authors:  Prescott G Woodruff; R Graham Barr; Eugene Bleecker; Stephanie A Christenson; David Couper; Jeffrey L Curtis; Natalia A Gouskova; Nadia N Hansel; Eric A Hoffman; Richard E Kanner; Eric Kleerup; Stephen C Lazarus; Fernando J Martinez; Robert Paine; Stephen Rennard; Donald P Tashkin; MeiLan K Han
Journal:  N Engl J Med       Date:  2016-05-12       Impact factor: 91.245

Review 4.  The Asthma-COPD Overlap Syndrome.

Authors:  Dirkje S Postma; Klaus F Rabe
Journal:  N Engl J Med       Date:  2015-09-24       Impact factor: 91.245

5.  Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.

Authors:  Juan P de-Torres; David O Wilson; Pablo Sanchez-Salcedo; Joel L Weissfeld; Juan Berto; Arantzazu Campo; Ana B Alcaide; Marta García-Granero; Bartolome R Celli; Javier J Zulueta
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

6.  Clinical and Radiologic Disease in Smokers With Normal Spirometry.

Authors:  Elizabeth A Regan; David A Lynch; Douglas Curran-Everett; Jeffrey L Curtis; John H M Austin; Philippe A Grenier; Hans-Ulrich Kauczor; William C Bailey; Dawn L DeMeo; Richard H Casaburi; Paul Friedman; Edwin J R Van Beek; John E Hokanson; Russell P Bowler; Terri H Beaty; George R Washko; MeiLan K Han; Victor Kim; Song Soo Kim; Kunihiro Yagihashi; Lacey Washington; Charlene E McEvoy; Clint Tanner; David M Mannino; Barry J Make; Edwin K Silverman; James D Crapo
Journal:  JAMA Intern Med       Date:  2015-09       Impact factor: 21.873

7.  Prevalence of COPD among symptomatic patients in a primary care setting.

Authors:  Barbara Yawn; David Mannino; Thomas Littlejohn; Gary Ruoff; Amanda Emmett; Ibrahim Raphiou; Glenn Crater
Journal:  Curr Med Res Opin       Date:  2009-11       Impact factor: 2.580

8.  Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims.

Authors:  Douglas W Mapel; Anand A Dalal; Christopher M Blanchette; Hans Petersen; Gary T Ferguson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-11-09

9.  Exacerbations in the pre- and post-COPD diagnosis periods.

Authors:  Barbara P Yawn; Peter Wollan; Matthew Rank
Journal:  Pragmat Obs Res       Date:  2013-04-30

10.  COPD surveillance--United States, 1999-2011.

Authors:  Earl S Ford; Janet B Croft; David M Mannino; Anne G Wheaton; Xingyou Zhang; Wayne H Giles
Journal:  Chest       Date:  2013-07       Impact factor: 9.410

View more
  13 in total

1.  Introducing the New COPD Pocket Consultant Guide App: Can A Digital Approach Improve Care? A Statement of the COPD Foundation.

Authors:  Byron Thomashow; James D Crapo; M Bradley Drummond; MeiLan K Han; Ravi Kalhan; Elisha Malanga; Vinny Malanga; David M Mannino; Stephen Rennard; Frank C Sciurba; Kristen S Willard; Robert Wise; Barbara Yawn
Journal:  Chronic Obstr Pulm Dis       Date:  2019-07-24

2.  Cigarette smoke-induced reduction of C1q promotes emphysema.

Authors:  Xiaoyi Yuan; Cheng-Yen Chang; Ran You; Ming Shan; Bon Hee Gu; Matthew C Madison; Gretchen Diehl; Sarah Perusich; Li-Zhen Song; Lorraine Cornwell; Roger D Rossen; Rick Wetsel; Rajapakshe Kimal; Cristian Coarfa; Holger K Eltzschig; David B Corry; Farrah Kheradmand
Journal:  JCI Insight       Date:  2019-05-21

3.  Design of the Redefining Therapy in Early COPD Study.

Authors:  MeiLan K Han; Wen Ye; Dong-Yun Kim; Prescott Woodruff
Journal:  Chronic Obstr Pulm Dis       Date:  2020-10

4.  Comparison of Compliance Rates and Treatment Efficiency in Home-Based with Hospital-Based Pulmonary Rehabilitation in COPD.

Authors:  Esra Pehlivan; Esra Yazar; Arif Balcı; Lütfiye Kılıç
Journal:  Turk Thorac J       Date:  2019-07-01

Review 5.  Diagnosing alpha-1 antitrypsin deficiency: the first step in precision medicine.

Authors:  Craig P Hersh
Journal:  F1000Res       Date:  2017-11-27

6.  Systematic literature review and meta-analysis of US-approved LAMA/LABA therapies versus tiotropium in moderate-to-severe COPD.

Authors:  MeiLan K Han; Riju Ray; Jason Foo; Chaienna Morel; Beth Hahn
Journal:  NPJ Prim Care Respir Med       Date:  2018-08-27       Impact factor: 2.871

7.  COPD and Rural Health: A Dialogue on the National Action Plan.

Authors:  Paul Moore; Graham T Atkins; Stephanie Cramb; Janet B Croft; Lisa Davis; Rowena J Dolor; Daniel Doyle; Maggie Elehwany; Cara James; Alana Knudson; John Linnell; David Mannino; Jean M Rommes; Akshay Sood; Eric Stockton; David N Weissman; Mike Witte; Eugenia Wyatt; William C Yarbrough; Barbara P Yawn; Lenora Johnson; Tom Morris; James P Kiley; Neyal J Ammary-Risch; Antonello Punturieri
Journal:  J Rural Health       Date:  2019-01-24       Impact factor: 4.333

Review 8.  GOLD in Practice: Chronic Obstructive Pulmonary Disease Treatment and Management in the Primary Care Setting.

Authors:  Barbara P Yawn; Matthew L Mintz; Dennis E Doherty
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-02-12

9.  Medicine Availability and Prescribing Policy for Non-Communicable Diseases in the Western Balkan Countries.

Authors:  Tanja Pekez-Pavlisko; Maja Racic; Srebrenka Kusmuk
Journal:  Front Public Health       Date:  2017-11-08

10.  The effect of delaying initiation with umeclidinium/vilanterol in patients with COPD: an observational administrative claims database analysis using marginal structural models.

Authors:  Ami R Buikema; Lee Brekke; Amy Anderson; Eleena Koep; Damon Van Voorhis; Lucie Sharpsten; Beth Hahn; Riju Ray; Richard H Stanford
Journal:  Multidiscip Respir Med       Date:  2018-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.